Analysts: Funding, investment for biotechs evolving

02/8/2008 | Star-Ledger (Newark, N.J.), The

Major pharmaceutical companies have begun to pay top dollar for biotech companies with promising pipelines, and venture capitalists have poured money into early-stage biotech companies, lessening the importance of private equity groups for funding in the life sciences. As a result, mergers and acquisitions are replacing IPOs as the preferred "exit strategy" for investors in startup firms.

View Full Article in:

Star-Ledger (Newark, N.J.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
South San Francisco, CA
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD